Shortcuts


Investor relations

Listed on NASDAQ since 1991 and a member of the S&P 500®, IDEXX Laboratories, Inc. (IDXX) is a global leader in veterinary diagnostics, software, and water microbiology testing.

Listen: Q3 2024 Results

Q3 2024 Results — October 31, 2024

Corporate Responsibility Report

At IDEXX, corporate responsibility is closely aligned with our business strategy and innovation agenda.

Read our 2023 report

Investor resources

Upcoming earnings dates

Q3 2024: October 31

Investor resources

Investor Relations
One IDEXX Drive
Westbrook, Maine 04092

1-207-556-8155 or 1-800-548-6733
Fax: 1-207-556-4427
Email

Latest news

IDEXX to Release 2024 Third Quarter Financial Results

IDEXX to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

IDEXX Announces Second Quarter Results

Q2 2024 Earnings Snapshot

IDEXX Announces Time Change for 2024 Second Quarter Financial Results Conference Call

IDEXX Releases 2023 Corporate Responsibility Report, Highlighting Progress Against Its Goals

IDEXX to Release 2024 Second Quarter Financial Results

IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing Pancreatitis

IDEXX to Present at Stifel Conference and Announces 2024 Investor Day

IDEXX Announces First Quarter Results

Q1 2024 Earnings Snapshot

IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences

IDEXX Launches Vello, an Innovative Pet Owner Engagement Software Solution, Streamlining How Practices and Clients Connect

IDEXX Announces Fourth Quarter and Full Year 2023 Results

Q4 2023 Earnings Snapshot

IDEXX Announces Revolutionary Slide-Free Cellular Analyzer, IDEXX inVue Dx, Transforming In-Clinic Workflows

IDEXX Expands Fecal Dx Antigen Testing Platform with Cystoisospora Detection, Marking the Second Platform Expansion in Less than Two Years

IDEXX Expands SNAP Platform with Leish 4Dx Test to Support Veterinarians Globally in Diagnosing Vector-borne Diseases

IDEXX Announces Third Quarter Results

Q3 2023 Earnings Snapshot   ​

IDEXX Releases 2022 Corporate Responsibility Report, Providing Environmental, Social, and Governance Updates

IDEXX Elects Irene Chang Britt to Board of Directors

IDEXX Announces Novel Diagnostic Test for Kidney Injury, Expanding the Veterinary Industry’s Most Comprehensive Renal Testing Portfolio

Groundbreaking IDEXX Study Reveals Opportunities to Increase Veterinary Practice Productivity

IDEXX Newsroom

Events and presentations

Third Quarter 2024 Earnings Conference Call
October 31, 2024, 8:30 am EDT

Morgan Stanley 22nd Annual Global Healthcare Conference
Wednesday, September 4, 11:30 am – 12:05 pm EDT

IDEXX Investor Day
August 15, 2024, 8:00 am EDT
View presentation

Second Quarter 2024 Earnings Conference Call
Tuesday, August 6, 2024, 9:00 am EDT

Stifel Jaws & Paws Conference
May 29, 2024, 10:55 am EDT

IDEXX First Quarter 2024 Earnings Conference Call
Wednesday, May 1, 2024, 8:30 am EDT

Raymond James 45th Annual Institutional Investors Conference
Monday, March 4, 2024, 11:00 am EST
View presentation

IDEXX Fourth Quarter 2023 Earnings Conference Call
Monday, February 5, 2023 EST

IDEXX Investor & Analyst Session at VMX
Monday, January 15, 2024, 1:00 pm EST
View presentation

Event video
Introducing the IDEXX inVue Dx Cellular Analyzer

 

 

IDEXX Third Quarter 2023 Earnings Conference Call
November 1, 2023, 8:30 am EDT

View all events and presentations